A61K 45/05
Immunological preparations stimulating the reticulo-endothelial system
Official title: {Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer}
A61K45/05 (Immunological preparations stimulating the reticulo-endothelial system) appears on 143 US grants and 172 published applications in this corpus.
Search patents in A61K- Granted patents
- 143
- Published applications
- 172
- Assignees
- 75
- Inventors
- 243
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 1 | 9 |
| 2018 | 2 | 18 |
| 2019 | 7 | 18 |
| 2020 | 34 | 46 |
| 2021 | 41 | 38 |
| 2022 | 10 | 5 |
| 2023 | 7 | 14 |
| 2024 | 7 | 9 |
| 2025 | 1 | 2 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of treatment of obesity27 Jan 2026US 12,533,333 B2Queen Mary University of London
- pH-triggered membrane peptide-mediated epitope tethering at cell surfaces29 Apr 2025US 12,285,462 B2University of Rhode Island Board of Trustees
- Use of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) agonists to improve ex vivo expansion of tumor infiltrating lymphocytes (TILS)30 Jul 2024US 12,048,717 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Method of treatment of obesity2 Jul 2024US 12,023,313 B2Queen Mary University of London
- Primary T-cell expansion25 Jun 2024US 12,016,883 B2NantBio, Inc.
- Systems and methods for molecular endotyping of rheumatoid arthritis30 Jul 2026US 2026/0221227 A1AMPEL BioSolutions, LLC
- Method Of Treatment Of Obesity11 Jun 2026US 2026/0157988 A1Queen Mary University of London
- Inhibition of TCF4/ITF2 in the Treatment of Cancer19 Feb 2026US 2026/0048075 A1Katholieke Universiteit Leuven
- Adeno-associated virus capsid having tissue tropism and use thereof12 Feb 2026US 2026/0041795 A1Shanghai Langsheng Biotechnology Co., Ltd
- Il-15 mutant-fc/il-15r alpha subunit-fc heterodimer and use thereof13 Nov 2025US 2025/0345397 A1Yifan Pharmaceutical (Shanghai) Co., Ltd.
Most cited
By later US patents
- Methods for the treatment of wounds using butyric acid salts and derivatives132US 5,858,365 ATrustees of Boston University · 1999
- Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense121US 5,021,234 A1991
- Refined detoxified endotoxin107US 4,866,034 ARibi ImmunoChem Research, Inc. · 1989
- Process for preparing immune complexes67US 5,254,339 A1993
- Derivatives of monophosphoryl lipid A60US 4,987,237 ARibi ImmunoChem Research, Inc. · 1991